Cargando…
In Systemic Sclerosis Patients, Peripheral Blood CD21(low) B Cells and Serum IL-4 and IL-21 Influence Joint Involvement
Systemic sclerosis (SSc) patients have an increased frequency of CD21(low) B cells and of serum interleukin-4 (IL-4) and IL-21, each possible markers of joint involvement in inflammatory arthritis. The aim of this study was to investigate the possible influence of CD21(low) B cells, IL-4, and IL-21...
Autores principales: | Pellicano, Chiara, Colalillo, Amalia, Carnazzo, Valeria, Redi, Serena, Basile, Valerio, Marino, Mariapaola, Basile, Umberto, Rosato, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532941/ https://www.ncbi.nlm.nih.gov/pubmed/37763102 http://dx.doi.org/10.3390/jpm13091334 |
Ejemplares similares
-
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients
por: Pellicano, Chiara, et al.
Publicado: (2022) -
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis
por: Leodori, Giorgia, et al.
Publicado: (2022) -
Type 2 cytokines and scleroderma interstitial lung disease
por: Pellicano, Chiara, et al.
Publicado: (2023) -
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients
por: Pellicano, Chiara, et al.
Publicado: (2023) -
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis
por: Pellicano, Chiara, et al.
Publicado: (2022)